DLA Piper Life Sciences

1/10/2025 2:31:57 PM

Life Sciences News in Italy: December 2024

By DLA Piper Life Sciences

Spotlight: Launch of the Master's Program in Pharmaceutical and Health Law We're pleased to announce we've launched the Master's Program...

12/19/2024 11:12:39 PM

By DLA Piper Life Sciences

As the New Year is fast approaching, we asked members of our Life Sciences team to share their predictions of what will be the key issues...

12/10/2024 12:34:50 PM

By DLA Piper Life Sciences

Download a copy of our November monthly briefing, which covers key updates and insights in the following areas: Medicinal...

12/10/2024 10:33:06 AM

By DLA Piper Life Sciences

Regulatory MDCG updates Q&A on vigilance terms under MDR and IVDR On 11 November 2024, the Medical Device Coordination Group (MDCG)...

9/9/2024 4:57:19 PM

By DLA Piper Life Sciences

Regulatory AIFA updates Guidelines for the classification and conduct of observational studies on medicines On 20 August 2024, the...

8/8/2024 8:27:37 AM

By DLA Piper Life Sciences

Regulatory AI Act enters into force On 12 July 2024, Regulation (EU) 2024/1689 (AI Act) was published in the EU Official Journal. The AI...

7/8/2024 2:23:11 PM

By DLA Piper Life Sciences

Regulatory EMA issues guidance on how to mitigate medicine shortages On 18 June 2024, the European Medicines Agency (EMA) issued guidance...

6/11/2024 9:55:39 AM

By DLA Piper Life Sciences

This month, our specialist life sciences team in Italy covers the key issues in the sector, including: Regulatory; White Collar Crime and...